Biomarkers and Drug Development: Regulatory Perspective | Christopher Leptak

#NIHHEAL: Endpoints for Pain Clinical Trials — Approaches & Accepted Endpoints for Biomarker DevicesПодробнее

Remote Digital Monitoring Workshop: Regulatory Guidance DDT - Chris Leptak & Panel DiscussionПодробнее

2019 FNIH Biomarkers Consortium Neuroscience Symposium Session 1 - Multimodal BiomarkersПодробнее

IBD Webinar 2021: Biomarkers & Drug Development- Regulatory PerspectiveПодробнее

Pathways for Using Biomarkers in Drug DevelopmentПодробнее

Biomarkers & Translational Medicine | Nucleate Translate Session 2 | 2023Подробнее

Advancing the Use of Biomarkers and Pharmacogenomics in Drug DevelopmentПодробнее

Role of Biomarkers in Drug Development | Jeffrey SiegelПодробнее

Early Drug Development Workshop on Building Effective Biomarker PlansПодробнее

ALS Biomarkers in Drug DevelopmentПодробнее

What Does Biomarker Qualification Do (And Not Do)?Подробнее

Critical success factors in the development and implementation of biomarkers in drug developmentПодробнее

Translational Science in Drug Development: Surrogate Endpoints, Biomarkers, and More - Day 2Подробнее

Biomarkers in NASH Drug DevelopmentПодробнее

Webinar Recording: Exploratory biomarker testing: to qualify or validate the assay?Подробнее

The Biomarker Qualification Process: A Roadmap for RequestorsПодробнее

Accelerating biomarker-guided drug development with Precision For MedicineПодробнее

Innovative Approaches to Biomarker Discovery in the Drug Development ProcessПодробнее

The role of biomarkers in drug developmentПодробнее